InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the complete record of transactions filed by Hackman Jeffrey S.. Director active across 2 companies, notably Comera Life Sciences Holdings, Inc.. Cumulatively, 9 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €6k. History available since 16 May 2025. The latest transaction was disclosed on 31 July 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Jeffrey S. Hackman is a declarant linked to Fennec Pharmaceuticals INC. as Chief Executive Officer and to Comera Life Sciences Holdings, Inc. as See Remarks. He has 9 filings in total, and among the recent filings we hold, the period runs from 2022-09-12 to 2026-08-03, with buys of EUR 6242 and sells of EUR 0, and the most common transaction nature being option exercise.